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Abstract
Background: Brazil has the second highest annual number of new leprosy cases. The aim of this 
study is to formally compare predictions of future new case detection rate (NCDR) trends and the 
annual probability of NCDR falling below 10/100,000 of four different modelling approaches in 
four states of Brazil: Rio Grande do Norte, Amazonas, Ceará, Tocantins.
Methods: A linear mixed model, a back-calculation approach, a deterministic compartmental 
model and an individual-based model were used. All models were fitted to leprosy data obtained 
from the Brazilian national database (SINAN). First, models were fitted to the data up to 2011, and 
predictions were made for NCDR for 2012–2014. Second, data up to 2014 were considered and 
forecasts of NCDR were generated for each year from 2015 to 2040. The resulting distributions of 
NCDR and the probability of NCDR being below 10/100,000 of the population for each year were 
then compared between approaches.
Results: Each model performed well in model fitting and the short-term forecasting of future 
NCDR. Long-term forecasting of NCDR and the probability of NCDR falling below 10/100,000 
differed between models. All agree that the trend of NCDR will continue to decrease in all states 
until 2040. Reaching a NCDR of less than 10/100,000 by 2020 was only likely in Rio Grande do 
Norte. Prediction until 2040 showed that the target was also achieved in Amazonas, while in Ceará 
and Tocantins the NCDR most likely remain (far) above 10/100,000.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusions: All models agree that, while incidence is likely to decline, achieving a NCDR 
below 10/100,000 by 2020 is unlikely in some states. Long-term prediction showed a downward 
trend with more variation between models, but highlights the need for further control measures to 
reduce the incidence of new infections if leprosy is to be eliminated.
Keywords
Leprosy; Brazil; Model comparison; LMER; Back-calculation; Compartmental; Individual-based 
model; Forecast
1. Introduction
Leprosy, or Hansen’s disease, is an infectious disease caused primarily by Mycobacterium 
leprae. It affects the skin, peripheral nerves, the mucosa of the upper respiratory tract and the 
eyes (Leprosy, 1982). Most people are able to clear the bacterium before disease occurs, or 
are resistant to the leprosy infection. The most likely route of transmission of leprosy is 
through aerosols (Hatta et al., 1995), with contacts closest to a patient with leprosy, in 
particular within household contacts, having the highest risk of acquiring the infection (Fine 
et al., 1997; Moet et al., 2006). Detection of leprosy is based on clinical signs and classified 
into paucibacillary (PB; ≤5 skin lesions) and multibacillary (MB; >5 skin lesions) leprosy. 
Currently, the main strategies to control leprosy are early detection of cases, and treatment 
with multidrug therapy (Global leprosy update, 2015). Chemoprophylaxis and immune-
prophylaxis are both potential interventions but are not yet routinely available.
Global elimination of leprosy has been a target for many years. In 1991, the World Health 
Assembly set a goal for “elimination of leprosy as a public health problem”, defined as a 
prevalence of less than 1 per 10,000, by the year 2000 (WHO, 1991). More recently, the 
World Health Organization (WHO) has formulated new targets for leprosy, which include 
global interruption of transmission or elimination by 2020, and reduction of grade-2 
disabilities in newly detected cases to below 1 per million population at global level by 2020 
(WHO, 2012). Currently, worldwide, more than 200,000 new cases of leprosy are detected 
annually, with India, Brazil and Indonesia accounting for around 80% of all new cases 
(Global leprosy update, 2015). This incidence has remained fairly stable over the past 
decade. Brazil has the second highest annual incidence with approximately 31,000 new 
cases and annual new case detection rate (NCDR) of 15.32 per 100,000 population in 2014 
(Ministry of health, 2015). Brazil was one of the countries that did not achieve elimination 
by 2000 (Castro et al., 2016). In 2011, the Ministry of Health defined an integrated action 
plan to reduce the burden of leprosy and to eliminate leprosy as a public health problem by 
2015. This plan includes active case finding and timely provision of treatment in prioritized 
municipalities, primarily located in the Amazon region (Ministry of Health, 2012).
The spatial distribution of leprosy in Brazil is known to be heterogeneous with the highest 
number of cases in the Northern, North-Eastern and Central-Western regions. Most high-risk 
states or districts are part of the Brazilian Amazon (Penna et al., 2009; Penna et al., 2013). In 
2014, ten states (37%) had a NCDR of more than 20 per 100,000, eight states (30%) a 
NCDR between 10 and 20 per 100,000, and nine states (33%) with a NCDR of less than 10 
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per 100,000 (Ministry of health, 2015). The highest rates can be found in the hyperendemic 
states of Mato Grosso and Tocantins with NCDR of 82.03 and 69.88 per 100,000, 
respectively. Also, within each state, leprosy is known to be unevenly distributed (Alencar et 
al., 2012; Kerr-Pontes et al., 2004). Although recent numbers show a slight declining trend 
in most states, more than two thirds of the states in Brazil can be regarded as highly 
endemic.
Although the WHO target is the interruption of leprosy transmission globally by 2020, it is 
clear that this will not be feasible due, for example, to the long incubation time of leprosy. 
We therefore focus on the feasibility of reducing the NCDR to low levels, which is likely to 
result in a reduced transmission. The aim of this study is to compare four modelling 
approaches being applied to leprosy in the context of assessing whether a NCDR of less than 
10 per 100,000 can be met by 2020 and predicting the annual probability of NCDR being 
below 10 per 100,000 in four states of Brazil: Rio Grande Do Norte (low endemic), 
Amazonas (medium-high endemic), Ceará (high endemic), and Tocantins (hyper endemic 
state). These states were purposively selected based on differences in levels of endemicity 
and historic patterns of leprosy NCDR.
Prediction of infectious disease patterns is complicated by the intrinsic non-linearity in the 
transmission process: more transmission leads to more infection which leads to more disease 
which leads to more transmission. Models are, by definition, abstract simplifications of 
reality, and in order to have confidence in their results, need to be challenged and validated. 
The best way to develop consensus advice is through comparison of outputs of different 
models. Consequently, we applied two statistical models and two mathematical transmission 
models to estimate future NCDR of leprosy from the same data, including: a linear mixed 
model, a Bayesian back-calculation approach, a deterministic compartmental model and the 
individual-based stochastic model SIMCOLEP. Back-calculation has shown potential to 
estimate numbers of newly infected individuals in Thailand (Crump and Medley, 2015). 
SIMCOLEP, which models the transmission and control of leprosy in a population 
structured by households, has been used to estimate future NCDR trends in Bangladesh, 
India, Brazil, and Indonesia, and to explore the potential impact of various interventions 
targeting household contacts (Blok et al., 2015a; de Matos et al., 2016; Fischer et al., 2011). 
In this study, we will explore the levels of agreement between these methods on future 
projections of the NCDR in the four chosen states. Model results are discussed to understand 
factors contributing to similarities and differences between methods.
2. Materials and methods
2.1. Data
Annual summary data by state were extracted via the SINAN database’s web interface 
(SINAN, 2016) for the years 1990–2012. The SINAN database is the Brazilian 
government’s repository for information on communicable diseases. The data retained for 
use in this study consisted of the annual number of new cases diagnosed (NC) and the 
annual new case discovery rate (NCDR) for MB and PB diagnoses combined, for 1990–
2012, and for MB cases separately, from 2000 to 2012, along with the population size. 
Equivalent data for 2013 and 2014 were retrieved from documents on the Brazilian 
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government’s health portal (Ministry of health, 2015; Ministry of health, 2014). Population 
size and NCDR for MB diagnoses were not reported in the 2013 and 2014 data tables. 
However, the NCDR for total diagnoses and the number of total diagnoses and MB 
diagnoses were still included. Using the NCDR for total diagnoses and the number of total 
diagnoses, we calculated the population size and finally generated the NCDR for MB 
diagnoses for 2013 and 2014. Four states were chosen for inclusion in the study using 
NCDR to indicate the level of endemicity in the state. The states selected were Tocantins 
(NCDR in 2014 69.9 per 100,000), Ceará (22.9), Amazonas (14.6) and Rio Grande do Norte 
(8.0) (Ministry of health, 2015). The data for the four states are presented in Fig. 1.
2.2. Estimation approaches
The fundamental purpose is to compare four different methods for probabilistic forecasting 
of leprosy. Each method (whether Bayesian or frequentist) yields the probability distribution 
of future outcomes, i.e. results not used for training the model. Four approaches were used: a 
linear mixed model, a Bayesian back-calculation approach, a deterministic compartmental 
model, and the individual-based stochastic model SIMCOLEP. In no case did we use data 
used for fitting or training as part of the test or evaluation set. By bringing these models 
together, we can evaluate to what extent predictions of NCDR are similar or different in 
order to validate and to improve predictive quality. The next sections provide a brief 
description of each approach with further details provided in the supplementary materials 
S1–S3. The model code of the linear mixed model, back-calculation approach and 
deterministic compartmental model are provided in supplementary material S5. The model 
code of the individual-based model SIMCOLEP can be found in Blok et al. (Blok et al., 
2015a).
2.3. Linear mixed models
A standard linear mixed effects regression was fitted to the data, as in Brook et al. (Brook et 
al., 2015). Specifically, we modelled the log of the annual new case detection rate as a linear 
function of time, with a random slope and intercept. We used only years 2001–2011 for the 
fitting. To model the uncertainty, we used the Metropolis algorithm (a Markov chain Monte 
Carlo (MCMC) procedure) to estimate the posterior joint distribution of the fixed effect 
estimates (overall slope and intercept), the variance of the random intercept and slope, and 
the residual error. Our method corresponds to a Bayesian analysis with noninformative 
priors; the maximum posterior density occurs at the maximum likelihood estimate. More 
specifically, we have assumed a random effect for the slope and intercept for each state; all 
states were included in common statistical model, though forecasts were only generated for 
the four states under consideration. Finally, conditional on these estimates, we simulated 
from the joint distribution of random effects to project forward.
2.4. Back-calculation
Back-calculation utilises information on diagnoses and the time between infection and 
diagnosis to make inferences about the infection dynamics of infectious diseases. For 
discrete time periods the number of diagnoses in any given period is the sum of the number 
of infections in the previous periods multiplied by the probability of diagnosis in the current 
period given the infection period. Leprosy can only be diagnosed in clinical cases, therefore 
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the time from infection to diagnosis can be subdivided into the period from infection to 
onset of clinical symptoms (the incubation period) and from onset of clinical symptoms to 
diagnosis (the detection delay). Crump and Medley (Crump and Medley, 2015) applied 
back-calculation to the national annual summary data for leprosy in Thailand. Here we use a 
similar model, with a two-stage time between infection and diagnosis where the hazard of 
being diagnosed in any year i given onset of symptoms in year j (j < i) is scaled by a 
parameter which might be interpreted as diagnostic effort or success within a period.
Parameters of the incubation period distribution (IPD) and detection delay distribution 
(DDD) were estimated from a small dataset with known, relatively short periods of exposure 
to leprosy infection (Crump and Medley, 2015). A Bayesian MCMC procedure was used to 
generate samples from the joint posterior probability distributions of these parameters which 
were subsequently used in the back-calculation.
The back-calculation model was implemented in the Stan probabilistic programming 
language (Stan Development Team, 2015) and run in the R statistical environment (R Core 
Team, 2016) via the rstan package (Stan Development Team, 2016). Details of the model are 
given in the Supplementary Material (S1). The model was similar to that of Crump and 
Medley (Crump and Medley, 2015) with some methodological changes, including having the 
expected number of new subclinical cases in a year be proportional to the number of extant 
undiagnosed clinical cases and the lack of data in the present study to inform the timing of 
changes in diagnostic effort and absence of data on grade 2 disability diagnoses. Changes in 
diagnostic effort were assumed to occur at the end of 1995, 2000 and 2007 for all analyses.
Resistance or susceptibility to leprosy and self-healing are not accounted for in the back-
calculation model. The data analysed are the annual number of new cases diagnosed. As a 
result, the numbers of subclinical and clinical cases inferred by the model refer specifically 
to those as-yet asymptomatic and symptomatic cases that will result in diagnosed cases in 
the future.
For each sample from the joint posterior distribution of parameters included in the back-
calculation model (diagnostic effort parameters, the annual proportion of infective 
individuals giving rise to a new subclinical case, the proportion of new diagnoses which are 
MB and the expected number of new diagnoses at equilibrium) observed values were 
simulated across the time period. New subclinical cases in each year were sampled from a 
negative binomial distribution with expectation proportional to the size of the infective pool 
and variance equal to the expectation squared. Binomial sampling was used to decide the 
year in which subclinical cases became clinical (based on the hazard function of the IPD) 
and clinical cases were diagnosed (based on the hazard function of the DDD and the 
diagnostic effort parameters). More information is provided in the Supplementary Material 
(S1).
To incorporate the uncertainty about the IPD and DDD parameters, multiple inference was 
used. The model was run repeatedly for any dataset with a randomly selected set of IPD and 
DDD parameters used in each run. Each of 1000 back-calculation runs were used to generate 
25 samples from the posterior probability distributions of values associated with the 
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infection process. The outputs from these runs were combined post-analysis to give 25,000 
samples for each state-analysis combination. Estimates of NCDR were generated from the 
posterior samples of the numbers of new cases using the same predictions of population size 
as used in the SIMCOLEP simulations. Summary statistics of these 25,000 samples from the 
posterior probability distributions form the primary results for this model reported here: 
means, 2.5th and 97.5th percentiles and the proportion of NCDR samples which less than 
10/100,000.
2.5. Compartmental model
We used a deterministic compartmental model similar to previously published models 
(Lechat et al., 1974; Lietman et al., 1997), which includes compartments for susceptible 
non-infected individuals (whether Bacillus Calmette–Guérin (BCG) vaccinated or not), 
latent infected individuals, symptomatic infected individuals, and individuals who are both 
diagnosed and treated. The compartments for infected individuals are stratified into 
paucibacillary and multibacillary leprosy infections (S2 Table 1). Flow from one 
compartment to another is defined by a directed acyclic graph (S2 Fig. 1), and the dynamics 
of flow from one compartment to another is defined by a set of differential equations (S2 
Table 2) that describe the change in size of these compartments over time. These equations 
model the factors that affect flow into and out of each compartment.
A set of initial values for the state variables of these equations and a set of values for the 
parameters (S2 Table 3) in these equations is necessary and sufficient to calculate model 
forecasts for a given time period. In order to calculate these initial values and parameter 
values, the following approach was used: some values were modelled as fixed-values that 
were derived from relevant literature (S2 Table 4), and some values were calculated using 
Markov Chain Monte Carlo (MCMC) sampling from prior distributions derived from 
relevant literature (S2 Table 5). This MCMC process calculates maximum-likelihood 
parameter values based on leprosy incidence data for the years 2001–2011. Gelman-Rubin 
statistics were used to evaluate chain convergence. The model is equivalent to a Bayesian 
analysis with noninformative priors.
Once calculated, these initial values and parameter values were used to generate a 
distribution of model forecasts. Residual variance from the training data was then applied to 
the model forecasts, to more accurately capture the uncertainty in the data. This distribution 
of forecasts was then used to calculate a mean, 2.5th percentile and 97.5th percentile model 
forecast for each forecast year, in order to generate credible intervals for the model forecasts.
2.6. SIMCOLEP
The individual-based model SIMCOLEP simulates the spread of M. leprae in a population 
structured in households. Dynamics of the population are described by births, movements 
between households, and deaths. Births are determined by birth rates and new-borns are 
placed in the household of their mother. Movements of individuals to another newly created 
or existing household occur after marriage, during adolescence or after becoming a 
widow(er). Deaths are determined by death rates (Blok et al., 2015b; Fischer et al., 2010).
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In the model, transmission of M. leprae occurs after direct contact of a susceptible individual 
with an infectious individual. We assumed that 20% of the population is susceptible (i.e. 
80% will not develop leprosy), based on the results of a previous modelling study (Fischer et 
al., 2010). Since the mechanism that underlies susceptibility is still unknown, susceptibility 
of an individual is randomly determined at birth. Two transmission processes are modelled 
separately: transmission in the general population and within-household transmission. 
Infectivity is determined by the product of the contact rate and the probability of infection 
during a contact. Each transmission process has its own contact rate. An infected individual 
will develop either PB or MB leprosy, which is randomly determined based on the 
distribution of the type of leprosy in each state. In the model, both types can be detected, 
treated and cured, but only MB leprosy is considered infectious. The natural history of 
leprosy is modelled following Meima et al. (Meima et al., 1999).
Leprosy control includes treatment with multidrug therapy (MDT), passive case detection, 
and active case finding. Passive case detection is reflected by estimated annual detection 
delays (Gamma distributed). Active case finding or household contact tracing are based on 
annual coverage rates (Ministry of health, 2015). After detection the patient is given MDT 
treatment and considered not to be infectious from then on. The model further assumes a 
protective effect of 60% of BCG vaccination prior to the infection (Schuring et al., 2009). 
Each state was modelled separately using SIMCOLEP. First the distribution of household 
sizes was fitted to the data in each state. Afterwards, leprosy NCDR trends were fitted to the 
data by calibrating contact rates and detection delays. Based on previous work, the contact 
rate within households was fixed at 0.98 (Fischer et al., 2010). The coverage of active case 
finding was set to 43% since 2003 in all states (Ministry of Health, 2011). For the long-term 
predictions, coverage rates were increased from 2014 onwards based on data (Ministry of 
health, 2015). The contact rate in the general population and annual detection delays were 
estimated for each state separately. Simulated new case detection rates were compared to the 
data using a log-likelihood function assuming a Poisson distribution. Using fitted values 
future predictions were made for 2012–2014 and finally 2015–2040. Final results were 
based on 1000 runs, which were used to calculate the mean and the 2.5th and 97.5th 
percentile. The probability of future NCDR being below 10 per 100,000 was calculated as 
the proportion of runs in which the target was achieved. More information is provided in the 
Supplementary Material (S3).
2.7. Analyses
Two sets of analyses were performed with each approach. In the first, the ability of the 
models to forecast was evaluated by omitting data from 2012 to 2014 and the models fitted 
to the remaining data. Short-term forecasts of NC and NCDR for the omitted data, for all 
diagnoses and MB diagnoses, were then compared between the approaches and the data.
Each of the analyses gave a probability distribution for NC and NCDR in the forecast years, 
for all and MB diagnoses. An approximate density function was fitted to each of these using 
the logspline package in R (Kooperberg, 2016) and the probability of the observed data 
points for 2012–2014 were calculated from these densities. The log likelihood of each 
observed value was computed based on the forecasted distribution (Bröcker and Smith, 
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2007), and the sums of the log likelihood over the years 2012–2014 by state, variable (NC 
and NCDR) and analysis for each diagnosis type (all or MB diagnoses) were calculated as 
indicators of which analysis gave the better short-term forecasts in these data sets.
Following this evaluation of the short-term model forecasts using observed data, the models 
were used to forecast trends. All of the data were included in the second analyses and 
forecasts of NCDR for combined paucibacillary and multibacillary diagnoses were 
generated for each year from 2015 to 2040. The resulting distributions of NCDR and 
probability of NCDR being below 10 per 100,000 of the population for each year were then 
compared between approaches.
3. Results
Figs. 2–5 show the major results for NCDR of all diagnosed leprosy cases. The figures 
relating to NC of all leprosy cases and both NC and NCDR for multibacillary diagnoses are 
provided in the Supplementary Material (S4).
Fig. 2 shows the mean and 95% forecast interval of predicted NCDR values from analyses 
excluding 2012–2014 observations for the period 1990–2014 from each model overlaid with 
the observed data points. Generally, SIMCOLEP predictions appear to follow the data more 
closely than the smoother fit of the back-calculation and the compartmental model, however 
all models provide a good visual fit to the observed data. There is noticeably more variation 
in the predictions from the back-calculation but the difference in variability varies between 
the States. Similar results are found for the predicted NCDR of MB cases and NC of all and 
MB cases (See S4).
The distribution of short-term forecasted NCDR values are presented by State and year in 
Fig. 3, this figure providing a more detailed look at the forecast distributions included in Fig. 
2 trends. Almost all data points lie within the distribution of predicted forecasts for all 
models. Table 1 contains sum of log likelihoods for the forecast data points for each 
analysis, with a higher (less negative) log likelihood indicating a better forecast. These 
values are relative to each other and do not have an independent interpretation. No model 
was clearly superior in terms of the sum of the log likelihoods of the forecast data, with the 
highest values for each analysis being shared evenly between SIMCOLEP, the 
compartmental model and the linear mixed model. The posterior densities for the back-
calculation model were very broad, giving lower density at any given point.
Fig. 4 shows the longer-term forecasts of NCDR by state and year. All modelling approaches 
predict a downward trend until 2040 in all four states. In 2020, the median NCDR is 
expected to remain above 10 per 100,000 in all states except for Rio Grande do Norte. In 
general, the compartmental model and SIMCOLEP are more optimistic than the back-
calculation approach. This is also reflected in the annual probability of NCDR falling below 
10 per 100,000 (Fig. 5). According to the compartmental model and SIMCOLEP, the 
probability of achieving the target increases to 100% in Rio Grande do Norte from 2024 and 
2025 onwards, respectively, whereas the linear mixed model and the back-calculation 
predicts a steady probability of 87% and 67%, respectively. In Amazonas the target can be 
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met with 80% probability in 2027, 2022, 2029, and 2019 according to the compartmental 
model, SIMCOLEP, back-calculation and the linear mixed model, respectively. The 
predictions for Ceará also show a discrepancy between the models. According to the linear-
mixed model, the back-calculation and SIMCOLEP, a NCDR below 10 per 100,000 is very 
unlikely in Ceará before 2040, while the compartmental model predicts that it becomes more 
likely closer to the year 2040. All models predict that Tocantins will not achieve the target 
incidence within the modelled time span.
4. Discussion
This paper compared the results of four approaches with the purpose to assess the feasibility 
of a NCDR below 10 per 100,000 by 2020 and to predict the annual probability of NCDR 
falling below 10 per 100,000 until 2040 in four states of Brazil. According to the prediction 
of our models, this is only feasible by 2020 in the state of Rio Grande do Norte. All models 
clearly showed that by 2020 the NCDR remains above 10 per 100,000 in Amazonas, Ceará 
and Tocantins, indicating that the target will not be met. Long-term predictions of the NCDR 
trend showed a downwards trend in all states, assuming that Brazil continues the current 
level of effort to control leprosy. Amazonas will likely achieve the target before 2040, while 
in Ceará and Tocantins the NCDR most likely remain (far) above 10 per 100,000 in the 
modelled time frame.
Our findings highlight the need for a shift in the current leprosy control strategy in order to 
achieve a NCDR of less than 10 per 100,000 in a reasonable time frame. Preventive 
interventions should be targeted on contacts of leprosy patients, since they have the highest 
risk of getting infected and developing clinical leprosy (Moet et al., 2004). Examples of such 
interventions include intensified contact tracing and providing chemoprophylaxis and/or 
immunoprophylaxis (vaccination) to contacts. Chemoprophylaxis with a single dose 
rifampicin is effective at preventing clinical leprosy (Moet et al., 2008). Recent modelling 
work showed that when provided in household contact only, it can speed up elimination (de 
Matos et al., 2016).
All models performed well in short-term forecasting of future diagnoses. Note that the 
performance of straightforward longitudinal analysis was comparable to the other 
procedures, with the exception of MB trends in Tocantins. Here, the regression continued to 
extrapolate a rising trend into the future, partially due to the use of a separate regression 
model for each outcome and to the use of a random effect for slope in the model. Other 
methods, such as the use of exponentially weighted smoothing, would be more influenced 
by the most recent data points than those further in the past, and may have improved 
performance. Similarly, regression models informed by prior distributions reflecting 
additional epidemiological information (e.g., a long term rising trend is less credible when 
all other regions are declining) may perform better.
There is a great difference between models for the longer-term forecasting of NCDR and the 
probability of NCDR falling below 10 per 100,000. The back-calculation does not include a 
mechanistic description of transmission but new subclinical cases arise at a rate proportional 
to the size of the infectious pool (with a naïve definition of the infectious pool as being all 
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the existing undiagnosed clinical cases). The change in NCDR beyond 2014 in the back-
calculation analysis is caused by a combination of the rate of incidence of new subclinical 
cases, the diagnostic effort (assumed to be the same as 2014) and population growth. The 
decline, as predicted by SIMCOLEP, can be attributed to leprosy control efforts. The model 
assumed a continuation of the leprosy control in 2014 in each state. This also includes 
household contact tracing with a coverage of 56%, 76%, 70%, and 85% in Rio Grande do 
Norte, Amazonas, Ceará and Tocantins, respectively (Ministry of health, 2015). Contact 
tracing and treatment further reduces transmission of leprosy.
There is greater variability in the predicted values from the back-calculation approach and 
this may be due to the simultaneous estimation of the associated parameters (diagnostic 
effort, multibacillary diagnosis proportion), the incorporation of uncertainty about these 
parameters into the outcomes and the assumed variation in simulating new subclinical 
infections. In contrast, predictions of SIMCOLEP were based on the best fit of estimated 
parameters, including the contact rate in the general population and detection delays. Other 
parameters, such as MDT treatment and household contact tracing were fixed to values 
obtained from data and literature, which also reduces variability. One of the benefits of 
multi-model comparisons is that they expose the variability due to model assumptions, but 
also exposes the differences in the way that uncertainty is handled. There is clearly a trade-
off between models accurately reflecting uncertainty, and being sufficiently precise to be 
useful to programme managers and policy makers. The back-calculation approach has very 
few (model) assumptions, and no fixed parameters, and more accurately reflects the 
possibility that, for example, a large number of people were infected in 2015 and have yet to 
be diagnosed, i.e. there is no information on the most recent infection rates. SIMCOLEP 
more accurately reflects current understanding of infection and essentially rules out dramatic 
changes in infection rates. We do not believe that there is a formal solution to enable these 
differences to be reconciled.
In this study we assessed the feasibility of reducing the NCDR to lower levels as a first step 
to achieve the target of interruption of transmission. However, the NCDR is not a reliable 
indicator to assess reduction of transmission, because it is also very dependent on the control 
efforts in a state. A better benchmark for cutting transmission would be to achieve zero 
leprosy cases among children (Smith et al., 2014).
The quality of reported data remains a concern in this study. The modelled States are among 
the poorest in Brazil, and they tend to have long(er) detection delays, which results in a large 
number of undiagnosed leprosy cases. Thus the national leprosy database, SINAN, tends to 
underestimate the real numbers of cases (Kerr-Pontes et al., 2004; Salgado et al., 2016). 
Targeted field surveys in the Amazon regions have resulted in many new cases detected 
(Barreto et al., 2012; Salgado et al., 2012). These undiagnosed cases remain a threat for 
breaking transmission in general (Smith et al., 2015). Reported detection rates are known to 
reflect operational variation in time, of which some are known and others unknown (Penna 
et al., 2009). It is believed that migration, especially in Tocantins, might explain to some 
extent the fluctuation in NCDR trends (Monteiro et al., 2015; Nobre et al., 2015). None of 
the models includes specific assumptions about migration and the possibility that cases are 
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diagnosed in a State different from that in which they were infected, and there is clearly a 
need for model development to include movement.
Another consideration is the uneven distribution of leprosy in each state (Alencar et al., 
2012; Kerr-Pontes et al., 2004). A state such as Rio Grande do Norte has (historically) 
relatively low NCDR, but nevertheless contains hyper endemic municipalities (Nobre et al., 
2015). Although our models predict that Rio Grande do Norte will very likely achieve the 
target of a NCDR below 10 per 100,000, continuous control efforts remain needed to bring 
down leprosy in high endemic municipalities.
5. Conclusions
The NCDR for leprosy is expected to continue to decline in Brazil, if it keeps the current 
level of efforts to control leprosy. However, these results show that the efforts made to 
achieve the gains to date are required for many years to come, due to the long incubation 
period of leprosy and hidden cases. By bringing together multiple models we have evaluated 
the trends using very different methods, to give more robust insight on the likely future 
trends of the NCDR. The model estimates suggest that there are high levels of ongoing 
transmission in some of these states, meaning that control efforts will need large increases in 
efficacy to reduce the NCDR to low levels over the next decade, and breaking transmission 
may require a shift in policy, such as providing post-exposure prophylaxis to contacts.
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Fig. 1. 
Observed new case detection rates (NCDR) and numbers of new cases (NC) for four 
Brazilian states. Data for combined paucibacillary and multibacillary diagnosis types from 
1990 to 2014 and for multibacillary diagnoses separately since 2001.
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Fig. 2. 
Comparison of predicted trends from four modelling approaches with the observed new case 
detection rates of leprosy in four states of Brazil. Model outcomes are represented by means 
(solid lines) and 95% prediction intervals (shaded areas).
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Fig. 3. 
Distribution of forecasted new case detection rates of leprosy in 2012–2014 by state, as 
predicted by four modelling approaches. The observed value for each state-year combination 
is indicated by a vertical black dashed line.
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Fig. 4. 
Predicted long-term NCDR trends from four modelling approaches by year and state. The 
horizontal black dashed line marks the elimination as a public health problem threshold of 
10 new cases per 100,000. Model forecasts are represented by means (solid lines) and 95% 
prediction intervals (shaded areas).
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Fig. 5. 
Probability of achieving a NCDR of less than 10 per 100,000 by year and state, as predicted 
by SIMCOLEP, compartmental, back-calculation and linear mixed models.
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